CN101057921B - Traditional Chinese medicine capsule for treating prostatic hyperplasia - Google Patents
Traditional Chinese medicine capsule for treating prostatic hyperplasia Download PDFInfo
- Publication number
- CN101057921B CN101057921B CN2007100156039A CN200710015603A CN101057921B CN 101057921 B CN101057921 B CN 101057921B CN 2007100156039 A CN2007100156039 A CN 2007100156039A CN 200710015603 A CN200710015603 A CN 200710015603A CN 101057921 B CN101057921 B CN 101057921B
- Authority
- CN
- China
- Prior art keywords
- parts
- prostatic hyperplasia
- rhizoma
- herba
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
Disclosed is a traditional Chinese medicinal capsule for treating prostate hyperplasia, wherein the raw materials include (by weight portions) pangolin scales 12-18 parts, Dangguiwei 12-18 parts, giant knotweed rhizome 27-32 parts, safflower 27-32 parts, acorus gramineus soland 3-7 parts, achyranthes and cyathula root 8-12 parts, herba patriniae 27-32 parts, earthworm 7-11 parts and knotgrass 15-20 parts.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of Chinese medicinal capsule preparation for the treatment of prostatic hyperplasia.
Background technology
Hyperplasia of prostate is a kind of commonly encountered diseases of elderly men, and mostly after 50 years old, its sickness rate also constantly raises age of onset with age.Its pathological change is mainly prostata tissue and epithelial proliferation, so claim hyperplasia of prostate.Along with improving constantly of living standards of the people and sanitary condition, China people's average life has reached 70 years old, hyperplasia of prostate has become the commonly encountered diseases of Urology Surgery, because it is in blocking that urinary tract caused, influence is urinated, directly threaten renal function, patient's life and health are brought serious harm, in geriatrics so primary disease is one of important topic.According to domestic statistics, the old people more than 50 years old has the prostatic hyperplasia that has of 36-38% approximately.Clinical manifestation is mainly frequent micturition, urgent micturition, carrying out property dysuria, urinary incontinence, acute urinary retention, hematuria, even the renal insufficiency symptom appears late period.
Hyperplasia of prostate is about the same in " difficulty in urination " of the traditional Chinese medical science.It is generally acknowledged that this type of patient's pathogenesis is: damp and hot being detained, the blood stasis internal memory is advocated the method for employing clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling in the treatment.But the Chinese medicine preparation of the prostatic hyperplasia medicine of Xiao Shouing mostly lays particular emphasis on activating blood circulation to dissipate blood stasis in the market, and prostatic hyperplasia is easily merged inflammation and shows as damp and hot characteristics attention deficiency of being detained, lay particular emphasis on vital energy regualting and blood circulation-promoting as niaosaitong tablets, the eliminating stagnation of stimulating the menstrual flow, and a little less than the power of invigorating blood circulation, QIANLIEXIN JIAONANG has only Herba Patriniae antipyretic simply.Though two kinds of medicines notice all and invigorate blood circulation that invigorates blood circulation selects medicine more gentle, and are slightly inadequate to the disease efficacy of a drug of hypertrophy, and there is not sensible agent to assist it.So the curative effect of medicine is not ideal enough clinically, want to obtain clinically curative effect preferably, must look after comprehensively, strengthen invigorating blood circulation and the power of heat clearing away, strengthen sensible merit and can obtain bigger curative effect.
Summary of the invention
Purpose of the present invention is exactly the technical deficiency that can have side effects in the Western medicine Drug therapy process in order to overcome, the Chinese medicinal capsule preparation of the prostatic hyperplasia that provide a kind of good effect, has no side effect.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of Chinese medicinal capsule for the treatment of prostatic hyperplasia, adopt Squama Manis, Radix Angelicae Sinensis, Rhizoma Polygoni Cuspidati, Caulis Sargentodoxae, Rhizoma Acori Graminei, Radix Achyranthis Bidentatae, Herba Patriniae, Pheretima,
Hold for feedstock production forms, add cold water after raw material is assorted and cover powder,, get supernatant through soaking, decoct, filtering, and be condensed into clear paste, and adding dry starch, mixing is granulated, drying, put cold, granulate, encapsulated, the weight portion that it is characterized in that raw material is 12～18 parts of Squama Maniss, 12～18 parts of Radix Angelicae Sinensis, 27～32 parts of Rhizoma Polygoni Cuspidati, 27～32 parts of Caulis Sargentodoxaes, 3～7 parts of Rhizoma Acori Graminei, 8～12 parts of Radix Achyranthis Bidentataes, 27～32 parts of Herba Patriniae, 7～11 parts of Pheretimas
Hold 15～20 parts.
A kind of Chinese medicinal capsule for the treatment of prostatic hyperplasia, preferred prescription is (by ratio of weight and the number of copies), 15 parts of Squama Maniss, 15 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Polygoni Cuspidati, 30 parts of Caulis Sargentodoxaes, 5 parts of Rhizoma Acori Graminei, 10 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Patriniae, 9 parts of Pheretimas,
Hold 18 parts.
The Chinese medicinal capsule cost that the present invention treats prostatic hyperplasia is low, and no obvious toxic-side effects can be treated prostatic hyperplasia effectively.
The specific embodiment
The invention will be further described below in conjunction with embodiment:
Embodiment 1:
At first get 15 parts of clean Squama Maniss by following component (weight portion), 15 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Polygoni Cuspidati, 30 parts of Caulis Sargentodoxaes, 5 parts of Rhizoma Acori Graminei, 10 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Patriniae, 9 parts of Pheretimas,
Hold 18 parts, decoct with water after the mixing 2 times, each 2 hours, add for the first time 10 times of amounts of water, add 8 times of amounts of water, collecting decoction for the second time, filter, get supernatant and filter, filtrate is concentrated into the clear paste of relative density 1.30 (80 ℃), add dry starch, mixing is granulated, drying, put cold, granulate, encapsulated, packing promptly.
Squama Manis has the Xiao of invigorating blood circulation Disorder, the effect of the stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, the main effect of using its blood circulation promoting and blood stasis dispelling of utilization herein.Zhang Xichun " Records of Tradition Chinese and Western Medicine in Combination " cloud: " the lightly seasoned property of Squama Manis is flat, gas raw meat and scurrying, and the property that it walks to scurry, very careful, so can declare logical internal organs, implement meridians, reach the pass key thoroughly, it is disease that blood clotting blood gathers, and all can open it ...
Radix Angelicae Sinensis has enriches blood, invigorates blood circulation, regulating menstruation, and pain relieving, the effect of intestine moistening is used Radix Angelicae Sinensis body, removing blood stasis Radix Angelicae Sinensis and blood Radix Angelicae Sinensis but enrich blood, and we use the power of Radix Angelicae Sinensis removing blood stasis, strengthen the merit of blood circulation promoting and blood stasis dispelling.Rhizoma Polygoni Cuspidati has multiple efficacies such as blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, promoting the function of the gallbladder to alleviate jaundice, expelling phlegm for arresting cough, the effect of mainly using its heat-clearing and toxic substances removing to invigorate blood circulation herein.
Caulis Sargentodoxae has the effect of heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis, inducing menstruation to relieve menalgia, and Herba Patriniae has heat-clearing and toxic substances removing, the effect of eliminating carbuncle evacuation of pus, stasis-dispelling and pain-killing, and both share the effect with heat clearing and blood circulation promoting detumescence.Rhizoma Acori Graminei has resuscitation inducing and mind tranquilizing, the effect of removing dampness to restore normal function of the stomach, and utilization herein is mainly sensible in order to removing dampness, and " book on Chinese herbal medicine newly organized " of Chen Shiduo has cloud, and " Rhizoma Acori Graminei on the stone, all tiny persons are all available, and the forefathers person that gets the Psychotria rubra (Lour.) Poir. gets all can leading to also of nine orifices.Rhizoma Acori Graminei all can be led to thinking in fact.Thinking is logical and nine orifices is all logical.”
Radix Achyranthis Bidentatae has functions such as promoting blood circulation to restore menstrual flow, invigorating the liver and kidney, bone and muscle strengthening, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards, mainly uses its tonneau water channel herein, and the energy priming is descending, arrives disease institute." book on Chinese herbal medicine is newly organized " has cloud, and " invigorating middle warmer is continuous extremely for Radix Achyranthis Bidentatae ... be apt to away twelve channels and collaterals, wide muscles and bones, and the tonifying YIN tonifying YANG removes waist knee joint ache, can lead to the puckery pain of urinary catheter, draws under all medicines.”
The Pheretima blood circulation promoting and blood stasis dispelling is gone into liver spleen lung meridian, clearing away heat and alleviating pain, collateral dredging, diuresis, relieving asthma, blood pressure lowering, use the effect of its heat clearing and blood circulation promoting diuresis at this.
But each raw material of the present invention also blended embodiment of the listed ratio of according to the form below (weight portion) is realized.Its processing technique is identical with embodiment 1.
1. case is selected: clinically select 60 routine patients at random.
2. diagnostic criteria: (1) clinical symptoms: urinate that increased frequency, urine line are thin at frequent micturition, urgent micturition, night, the sound of rain pattering, radiating pain, dysuria.(2) anus refers to inspection: prostate increases, and Rolandic fissure shoals, disappears or swells.(3) ultrasound diagnosis: prostate increases, and intravesical does not have residual urine or residual urine is arranged.
3. Therapeutic Method: each 4 of capsule, every day three times.Take continuously, one month is a course of treatment, observes 2 courses of treatment.
4. curative effect is judged:
Produce effects: clinical symptom disappearance, the bladder residual urine disappears.
Take a turn for the better: the symptom of urinating is obviously improved, and the bladder residual urine obviously reduces 20～30ml or disappearance.
Invalid: the symptom of urinating and bladder residual urine do not have obvious improvement.
5. therapeutic effect: use the present invention to treat 60 examples, produce effects 25 examples as a result, 35 examples that take a turn for the better, invalid 0 example, obvious effective rate is 41.7%, and improvement rate is 58.3%, and inefficiency is 0, and total effective rate is 100%.
Claims (2)
1. a Chinese medicinal capsule for the treatment of prostatic hyperplasia adopts Squama Manis, Radix Angelicae Sinensis, Rhizoma Polygoni Cuspidati, Caulis Sargentodoxae, Rhizoma Acori Graminei, Radix Achyranthis Bidentatae, Herba Patriniae, Pheretima Herba Polygoni Avicularis is that feedstock production forms, and adds cold water after raw material is assorted and covers powder, through soaking, decoct, filter, get supernatant, and be condensed into clear paste, add dry starch, mixing is granulated, dry, put cold, granulate, encapsulated, it is characterized in that: the weight portion of raw material is, 12～18 parts of Squama Maniss, 12～18 parts of Radix Angelicae Sinensis, 27～32 parts of Rhizoma Polygoni Cuspidati, 27～32 parts of Caulis Sargentodoxaes, 3～7 parts of Rhizoma Acori Graminei, 8～12 parts of Radix Achyranthis Bidentataes, 27～32 parts of Herba Patriniae, 15～20 parts of Pheretima 7～11 Fen ， Herba Polygoni Avicularis.
2. Chinese medicinal capsule for the treatment of prostatic hyperplasia, it is characterized in that: the feedstock production by following weight portion forms, 15 parts of Squama Maniss, 15 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Polygoni Cuspidati, 30 parts of Caulis Sargentodoxaes, 5 parts of Rhizoma Acori Graminei, 10 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Patriniae, 9 parts of Pheretimas, 18 parts of Herba Polygoni Avicularis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100156039A CN101057921B (en) | 2007-05-14 | 2007-05-14 | Traditional Chinese medicine capsule for treating prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100156039A CN101057921B (en) | 2007-05-14 | 2007-05-14 | Traditional Chinese medicine capsule for treating prostatic hyperplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101057921A CN101057921A (en) | 2007-10-24 |
| CN101057921B true CN101057921B (en) | 2011-06-22 |
Family
ID=38864324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100156039A Expired - Fee Related CN101057921B (en) | 2007-05-14 | 2007-05-14 | Traditional Chinese medicine capsule for treating prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101057921B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101628060B (en) * | 2009-08-05 | 2011-07-20 | 刘志美 | Medicinal decoction used for treating prostate hyperplasia |
-
2007
- 2007-05-14 CN CN2007100156039A patent/CN101057921B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 詹慧春 等.中医药治疗前列腺增生症的临床研究概况.《实用中西医结合临床》.2003,第3卷(第1期),59-61. |
| 詹慧春等.中医药治疗前列腺增生症的临床研究概况.《实用中西医结合临床》.2003,第3卷(第1期),59-61. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101057921A (en) | 2007-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411808B (en) | Method for preparing Chinese medicine for treating heat intestine and stomach type constipation | |
| CN101081261B (en) | Medicine for treating hemorrhoids | |
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN101721642A (en) | Medicine for treating calculus of urinary system and preparation method thereof | |
| CN101862428B (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN102579897A (en) | Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN101143171B (en) | Traditional Chinese medicine and its preparation method and its application | |
| CN102475868A (en) | Anti-rheumatism medicinal liquor | |
| CN107375845A (en) | The topical composition and its application method that dispelling wind and eliminating dampness is clearing and activating the channels and collaterals | |
| CN101057921B (en) | Traditional Chinese medicine capsule for treating prostatic hyperplasia | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN101530516B (en) | Chinese medicament for treating appendicitis | |
| CN100534505C (en) | Chinese-medicinal powder for treating acne | |
| CN100546640C (en) | A kind of Chinese medicine composition of orally taken for curing cyclomastopathy | |
| CN103432401B (en) | Traditional Chinese medicine powder prepared from three flowers, five seeds and six whites for treating lung cancer | |
| CN102600272A (en) | Traditional Chinese medicine for treatment of orthopedic disease | |
| CN102000190A (en) | Medicament for treating kidney stone | |
| CN101843856A (en) | Chinese medicinal herb for treating cancer | |
| CN104958485A (en) | Chinese medicinal composition for treating bedsore and application | |
| CN105998880B (en) | Oral medicine for treating hemorrhoids and preparation method thereof | |
| CN1939526A (en) | Stasis arthralgia and its production | |
| CN1299728C (en) | Capsules of Tokyo violet, dandelion and flavescent sophora root and their making method | |
| CN1141105C (en) | Cancer curing medicine liquid | |
| CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110622 Termination date: 20120514 |